R. Gatsi and HA. Baylis. . Rhythmic processes are an integral part of life of most organisms. Biological rhythms of less than a day are called ultradian rhythms. In C. elegans, ultradian rhythms include pharyngeal pumping, defecation, and ovulation. There is a growing body of evidence which supports the hypothesis that these rhythmic functions share a common molecular mechanism1. A central component of this pathway is the second messenger IP3. IP3 is produced by the action of phospholipase C in response to external stimuli. IP3 binds to IP3R located in the ER and regulates the release of calcium. IP3Rs are regulated by a broad range of molecules and proteins including Ca2+ itself and ATP. Signalling through IP3,
itr-1 (IP3R) and Ca2+ are clearly involved in the control of rhythms in pumping, defecation, and ovulation 2,3,4,5. Interestingly, genetic analysis also suggests that ultradian rhythms are linked to mechanisms that control the rates of growth and ageing. In particular clk and gro genes regulate both types of processes 6,7.. We are currently dissecting the role of IP3 signalling in the regulation of timing in C. elegans by analysing the relationship between rhythmic processes, such as pharyngeal pumping, and rates such as the rate of growth and ageing. We have evidence which suggests that IP3 signalling might play a central role in these processes. We have shown that, in addition to changes in ultradian rhythms, mutants of
itr-1 show alteration in growth rate (see also Dal Santo et al, 1999) and ageing. We have characterised these changes in more detail. In particular our results indicate that the ATP-binding regulatory site of the IP3Rs might play a significant role in these processes. In addition, phenotypic characterization of suppressor mutants of
itr-1 (
sa73) (ts l.o.f. mutant) suggest that growth rate may be regulated independently of other phenotypes. 1. Baylis HA. (2005) Cell. 123, 5-7. 2. Clandinin TR, DeModena JA & Sternberg PW (1998) Cell. 92, 523-533.. 3. Dal Santo P et al (1999) Cell. 98, 757-767.. 4. Walker DS., et al. (2002) Mol Biol Cell. 13, 1329-1337.. 5. Yin X, Gower NJ, Baylis HA & Strange K. (2004) Mol Biol Cell. 15, 38-49.. 6. Branicky R, Benard C and Hekimi S (2000). Bioessays 22, 48-56.. 7. Hekimi S, Lakowski B, Barnes TM, Ewbank J (1998) J. Trends Genet. 14, 14-20.